CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

Näytä muut versiot (1)

Bibliografiset tiedot
Päätekijät:	Guang Wang, Juan Fu, Mulin Liu, Qin Zheng
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Public Library of Science (PLoS) 2024-01-01
Sarja:	PLoS ONE
Linkit:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI

Samankaltaisia teoksia

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
Tekijä: Guang Wang, et al.
Julkaistu: (2024-01-01)

The Role of CXC Chemokines in Cardiovascular Diseases
Tekijä: Xiyi Lu, et al.
Julkaistu: (2022-05-01)

FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
Tekijä: N. V. Kipich, et al.
Julkaistu: (2014-07-01)

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
Tekijä: Tesfaye Wolde, et al.
Julkaistu: (2024-02-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
Tekijä: GhH Hassanshahiraviz, et al.
Julkaistu: (2005-10-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
Tekijä: GhH Hassanshahiraviz, et al.
Julkaistu: (2005-03-01)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
Tekijä: Li-Peng Pei, et al.
Julkaistu: (2022-06-01)

The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain.
Tekijä: Anthony, D, et al.
Julkaistu: (1999)

CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
Tekijä: Kayode Komolafe, et al.
Julkaistu: (2022-01-01)

Biophysical characterization of the CXC chemokine receptor 2 ligands
Tekijä: Patrick Martin, et al.
Julkaistu: (2024-01-01)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
Tekijä: Jianming Tang, et al.
Julkaistu: (2022-08-01)

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
Tekijä: Valentina Brancato, et al.
Julkaistu: (2024-12-01)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
Tekijä: Munan Zhao, et al.
Julkaistu: (2023-01-01)

CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
Tekijä: Na Wu, et al.
Julkaistu: (2025-02-01)

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
Tekijä: Liang Ma, et al.
Julkaistu: (2025-01-01)

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.
Tekijä: Mehrnaz Gharaee-Kermani, et al.
Julkaistu: (2012-01-01)

Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in silico and in vitro study
Tekijä: Fuchuan Jiang, et al.
Julkaistu: (2025-01-01)

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma
Tekijä: Xiaoxuan Tang, et al.
Julkaistu: (2025-02-01)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
Tekijä: Fang Zhang, et al.
Julkaistu: (2023-02-01)

Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis
Tekijä: Erbao Chen, et al.
Julkaistu: (2018-02-01)

A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer
Tekijä: Hossein Hozhabri, et al.
Julkaistu: (2022-06-01)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
Tekijä: Zhiheng Lin, et al.
Julkaistu: (2022-09-01)

Identification of CAPG as a potential prognostic biomarker associated with immune cell infiltration and ferroptosis in uterine corpus endometrial carcinoma
Tekijä: Junwei Liu, et al.
Julkaistu: (2024-11-01)

Exploring Chemokine Homodimer Stability: Structural Insights into CXC and CC Interfaces
Tekijä: David Budean, et al.
Julkaistu: (2024-11-01)

Structural basis of CXC chemokine receptor 1 ligand binding and activation
Tekijä: Naito Ishimoto, et al.
Julkaistu: (2023-07-01)

Function of chemokine (CXC motif) ligand 12 in periodontal ligament fibroblasts.
Tekijä: Yuichi Yashiro, et al.
Julkaistu: (2014-01-01)

CXC chemokines function as a rheostat for hepatocyte proliferation and liver regeneration.
Tekijä: Gregory C Wilson, et al.
Julkaistu: (2015-01-01)

Prognostic Significance and Immune Cell Infiltration Analysis of CXC Chemokines in Glioblastoma
Tekijä: LIU Fangyuan, et al.
Julkaistu: (2021-04-01)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
Tekijä: Kang He, et al.
Julkaistu: (2023-01-01)

UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion
Tekijä: Sijia Ma, et al.
Julkaistu: (2023-10-01)

Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes
Tekijä: Qiu Sang, et al.
Julkaistu: (2024-07-01)

Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity.
Tekijä: Tony Ngo, et al.
Julkaistu: (2020-04-01)

Cloning and bioactivity analysis of a CXC ligand in black seabream <it>Acanthopagrus schlegeli</it>: the evolutionary clues of ELR<sup>+</sup>CXC chemokines
Tekijä: Kezhi Xing, et al.
Julkaistu: (2008-11-01)

A comprehensive analysis of CEBPA on prognosis and function in uterine corpus endometrial carcinoma
Tekijä: Jiaxing Wang, et al.
Julkaistu: (2024-10-01)

Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
Tekijä: Qi Zhang, et al.
Julkaistu: (2024-02-01)

Early detection of uterine corpus endometrial carcinoma utilizing plasma cfDNA fragmentomics
Tekijä: Jing Liu, et al.
Julkaistu: (2024-07-01)

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
Tekijä: Xiaoyuan Lu, et al.
Julkaistu: (2022-01-01)

A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins
Tekijä: Lee, A, et al.
Julkaistu: (2019)

Structure basis for the modulation of CXC chemokine receptor 3 by antagonist AMG487
Tekijä: Haizhan Jiao, et al.
Julkaistu: (2023-11-01)

The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
Tekijä: Katharina Helene Susek, et al.
Julkaistu: (2018-09-01)